2011
DOI: 10.1016/j.jclinepi.2011.04.014
|View full text |Cite
|
Sign up to set email alerts
|

GRADE guidelines: 8. Rating the quality of evidence—indirectness

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
830
0
23

Year Published

2012
2012
2020
2020

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 1,479 publications
(853 citation statements)
references
References 16 publications
0
830
0
23
Order By: Relevance
“…0·47 to 1·01; I 2  = 37·3 per cent). Owing to inconsistency in the direction of effect on wound dehiscence and a moderate risk of bias, the quality of evidence was downgraded to low43. The NNT to avoid wound dehiscence was 17; as the treatment effect was not significant, the 95 per cent c.i.…”
Section: Resultsmentioning
confidence: 99%
“…0·47 to 1·01; I 2  = 37·3 per cent). Owing to inconsistency in the direction of effect on wound dehiscence and a moderate risk of bias, the quality of evidence was downgraded to low43. The NNT to avoid wound dehiscence was 17; as the treatment effect was not significant, the 95 per cent c.i.…”
Section: Resultsmentioning
confidence: 99%
“…The quality of the overall evidence (confidence in the estimates) was moderate to high for efficacy vs. placebo, low to moderate for side effects (limited by imprecision) and likely low for the ranking suggesting superiority of escitalopram (limited by indirectness of comparative data). 42,43 In conclusion, given the promising positive effects of SSRIs on hot flashes and the likely favorable side effect profile, their use seems to be an acceptable option for treating menopausal women with hot flashes and is a good alternative to HRT. Future trials should investigate different SSRIs over a long time period (e.g., 6-12 months) and should not use placebo for comparison in order to provide high-quality comparative effectiveness evidence.…”
Section: Implications For Practice and Researchmentioning
confidence: 99%
“…Network meta-analyses, also called multiple-treatment comparison meta-analyses, provide an approach to simultaneous consideration of the relative effectiveness of multiple treatment alternatives [17,23,29]. The benefit of a network meta-analysis includes the potential for providing indirect evidence, which refers to the determination of relative treatment effects between two treatments when head-to-head trials (ie, direct evidence) are not available [29].…”
Section: Introductionmentioning
confidence: 99%